Proteomics discovery of chemoresistant biomarkers for ovarian cancer therapy
- 21 September 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Proteomics
- Vol. 13 (10) , 905-915
Abstract
Introduction: Chemoresistance is a major challenge to current ovarian cancer chemotherapy. It is important to identify biomarkers to distinguish chemosensitive and chemoresistant patients. Areas covered: We review the medical literature, discuss MS-based technologies with respect to chemoresistant ovarian cancer and summarize the promising chemoresistant biomarkers identified. In addition, the challenges and future perspectives of biomarker discovery research are explored. With the employment of mass spectrometry-based (MS-based) proteomics, biomarker discovery of ovarian cancer has made great progress in the last decade. Many potential biomarkers were identified by MS-based proteomics technologies, some of which have been validated for further extensive studies in clinical settings. Expert commentary: The discovery of chemoresistant biomarkers is a newly developing area and may provide a clue for predicting chemotherapeutic response and discover therapeutic targets for paving the way of personalized medicine. Multiple complementary MS-based proteomics approaches hold promise for finding novel therapeutic targets in ovarian cancer treatment.Keywords
Funding Information
- Cancer Care Centre, St George's Hospital (190481)
This publication has 69 references indexed in Scilit:
- Targeted Data Extraction of the MS/MS Spectra Generated by Data-independent Acquisition: A New Concept for Consistent and Accurate Proteome AnalysisMolecular & Cellular Proteomics, 2012
- Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomicsProteomics, 2011
- A Serum Protein Profile Predictive of the Resistance to Neoadjuvant Chemotherapy in Advanced Breast CancersMolecular & Cellular Proteomics, 2011
- N,N-Dimethyl Leucines as Novel Isobaric Tandem Mass Tags for Quantitative Proteomics and PeptidomicsAnalytical Chemistry, 2010
- A Quantitative Proteomics Analysis of Subcellular Proteome Localization and Changes Induced by DNA DamageMolecular & Cellular Proteomics, 2010
- Modification‐specific proteomics: Strategies for characterization of post‐translational modifications using enrichment techniquesProteomics, 2009
- Dissecting protein function and signaling using protein microarraysCurrent Opinion in Chemical Biology, 2009
- Identification of Platinum-Resistance Associated Proteins through Proteomic Analysis of Human Ovarian Cancer Cells and Their Platinum-Resistant SublinesJournal of Proteome Research, 2006
- Treatment goals in ovarian cancerInternational Journal of Gynecological Cancer, 2005
- Multiplexed Protein Quantitation in Saccharomyces cerevisiae Using Amine-reactive Isobaric Tagging ReagentsMolecular & Cellular Proteomics, 2004